<VariationArchive RecordType="classified" VariationID="8518" VariationName="NC_000019.10:g.(13214609_13224667)_(13286966_13300549)del" VariationType="Deletion" Accession="VCV000008518" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2018-05-09" MostRecentSubmission="2018-05-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="23557" VariationID="8518">
      <GeneList>
        <Gene Symbol="CACNA1A" FullName="calcium voltage-gated channel subunit alpha1 A" GeneID="773" HGNC_ID="HGNC:1388" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13206442" stop="13506479" display_start="13206442" display_stop="13506479" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13317255" stop="13617273" display_start="13317255" display_stop="13617273" Strand="-" />
          </Location>
          <OMIM>601011</OMIM>
          <Haploinsufficiency last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC121852980" FullName="Sharpr-MPRA regulatory region 13658" GeneID="121852980" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13268115" stop="13268409" display_start="13268115" display_stop="13268409" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC126862864" FullName="MED14-independent group 3 enhancer GRCh37_chr19:13371552-13372751" GeneID="126862864" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13260738" stop="13261937" display_start="13260738" display_stop="13261937" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC126862865" FullName="CDK7 strongly-dependent group 2 enhancer GRCh37_chr19:13385818-13387017" GeneID="126862865" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13275004" stop="13276203" display_start="13275004" display_stop="13276203" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129391066" FullName="MPRA-validated peak3368 silencer" GeneID="129391066" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13215601" stop="13215801" display_start="13215601" display_stop="13215801" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130063718" FullName="ATAC-STARR-seq lymphoblastoid active region 14127" GeneID="130063718" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13215852" stop="13216221" display_start="13215852" display_stop="13216221" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130063719" FullName="ATAC-STARR-seq lymphoblastoid silent region 10204" GeneID="130063719" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13234652" stop="13234701" display_start="13234652" display_stop="13234701" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130063720" FullName="ATAC-STARR-seq lymphoblastoid silent region 10205" GeneID="130063720" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13277262" stop="13277321" display_start="13277262" display_stop="13277321" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130063721" FullName="ATAC-STARR-seq lymphoblastoid active region 14132" GeneID="130063721" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13277642" stop="13277811" display_start="13277642" display_stop="13277811" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000019.10:g.(13214609_13224667)_(13286966_13300549)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" outerStart="13214609" innerStart="13224667" innerStop="13286966" outerStop="13300549" display_start="13214609" display_stop="13300549" variantLength="62300" />
      </Location>
      <OtherNameList>
        <Name>86.1-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.(13214609_13224667)_(13286966_13300549)del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.(13214609_13224667)_(13286966_13300549)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="601011.0032" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">Deletion from gene CACNA1A minimally including exons 20 through 38, and possibly also spanning exon 19, plus flanking intronic sequences.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000019.10:g.(13214609_13224667)_(13286966_13300549)del AND Episodic ataxia type 2" Accession="RCV000009044" Version="8">
        <ClassifiedConditionList TraitSetID="2343">
          <ClassifiedCondition DB="MedGen" ID="C1720416">Episodic ataxia type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2009-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-05-09" MostRecentSubmission="2018-05-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19586927</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2343" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1620" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Episodic ataxia with nystagmus</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nystagmus-associated episodic ataxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Episodic ataxia type 2</ElementValue>
                <XRef ID="Episodic+Ataxia+with+Nystagmus/2620" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007163" DB="MONDO" />
                <XRef ID="420932006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebellopathy, hereditary paroxysmal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia, familial, paroxysmal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acetazolamide-responsive, hereditary, paroxysmal, cerebellar ataxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acetazolamide-responsive episodic ataxia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebellar ataxia, paroxysmal, Acetazolamide-responsive</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EA2</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">APCA</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CAPA</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9602" />
                <XRef ID="9602" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <XRef ID="97" DB="Orphanet" />
              <XRef ID="C1720416" DB="MedGen" />
              <XRef ID="MONDO:0007163" DB="MONDO" />
              <XRef Type="MIM" ID="108500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="29261" SubmissionDate="2017-09-07" DateLastUpdated="2018-05-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601011.0032_EPISODIC ATAXIA, TYPE 2" title="CACNA1A, 86.1-KB DEL_EPISODIC ATAXIA, TYPE 2" />
        <ClinVarAccession Accession="SCV000029261" DateUpdated="2018-05-09" DateCreated="2013-04-04" Type="SCV" Version="6" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a proband with episodic ataxia type 2 (EA2; 108500), Labrum et al. (2009) identified a heterozygous 86.1-kb deletion in the CACNA1A gene, resulting in deletion of exons 20 to 38. The deletion was not detected in a panel of 180 normal control chromosomes.</Attribute>
              <Citation>
                <ID Source="PubMed">19586927</ID>
              </Citation>
              <XRef DB="OMIM" ID="108500" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CACNA1A" />
          </GeneList>
          <Name>CACNA1A, 86.1-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">86.1-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601011.0032" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPISODIC ATAXIA, TYPE 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="29261" TraitType="Disease" MappingType="Name" MappingValue="EPISODIC ATAXIA, TYPE 2" MappingRef="Preferred">
        <MedGen CUI="C1720416" Name="Episodic ataxia type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

